04 09 / 2026
Rapid Micro Biosystems to Participate in Upcoming Investor Conferences
LEXINGTON, Mass., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products,
07 08 / 2026
Rapid Micro Biosystems Reports Second Quarter 2026 Financial Results
Reports  second quarter 2026 total revenue of $8.1 million, representing 11% growth compared to the second quarter of 2025 Achieved a significant milestone with the 200th Growth Direct system placed globally; placed four Growth Direct systems and completed nine validations in the second quarter
13 05 / 2026
Rapid Micro Biosystems Reports First Quarter 2026 Financial Results
Reports first quarter 2026 total revenue of $8.0 million, representing 11% growth compared to the first quarter of 2025 Placed 6 Growth Direct systems in the first quarter 2026 compared to 3 systems in the first quarter of 2025 First quarter 2026 product revenue increased 36% year-over-year;